also on other fortune lists

company facts

f500 stats

Fortune 500

John Still — Thermo Fisher Scientific


Thermo Fisher Scientific


This manufacturer of analytical instruments, equipment, software, and services for the scientific research industry has about 70,000 employees around the world.

Looking for leads, investment insights, or competitive intelligence?


Marc N. Casper

CEO Title

President, Chief Executive Officer & Director




Scientific,Photographic and Control Equipment

HQ Location

Waltham, Mass.

Years on Fortune 500 List




Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$20,91814.5%
Profits ($M)$2,225.010.1%
Assets ($M)$56,669
Total Stockholder Equity ($M)$25,413
Market Value — as of March 29, 2018 ($M)$82,952
Profit Ratios
Profit as % of Revenues10.6%
Profits as % of Assets3.9%
Profits as % of Stockholder Equity8.8%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)5.59
EPS % Change (from 2016)9.8%
EPS % Change (5 year annual rate)11.7%
EPS % Change (10 year annual rate)12.5%
Total Return
Total Return to Investors (2017)35.1%
Total Return to Investors (5 year, annualized)25.0%
Total Return to Investors (10 year, annualized)13.0%
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Thermo Fisher Scientific

Biotech Giant Thermo Fisher Stops Selling DNA Sequencers in Repressive Chinese Region

Xinjiang is home to China's Uighur minority and subject to heavy surveillance.

Read More →
The Best Investing Advice for 2018 From Fortune’s Experts

Insights from our annual roundtable on the best stocks and the biggest risks.

Read More →
Why the Companies That Actually Make Your Drugs Are in a Merger Frenzy

Shifts in the biopharma economy have big ripple effects.

Read More →
Scientific Instrument Giant Thermo Fisher to Buy Patheon for About $5.2 Billion

As it looks to become a one-stop shop for contract drug development and manufacturing.

Read More →
Why the Supreme Court May Hear the Case of the Dancing Baby

With a divided court, IP cases move to the top of the list.

Read More →